MERCER GLOBAL ADVISORS INC /ADV

Position in INCY — Incyte Corp

CIK 853758 DENVER, CO

Position in INCY

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$13,173,225

+$4,395,030 QoQ

Shares Held

116,207

+24.6% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#145

of 849 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 26% Shared 0% None 74%

Healthcare · as of Jun 30, 2026

MERCER GLOBAL ADVISORS INC /ADV holds $302,411,362 across 140 Biotechnology names. INCY ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	941,283	$124,936,492
2	CAPR	Capricor Therapeutics, Inc.	802,732	$19,329,786
3	ORMP	Oramed Pharmaceuticals Inc.	3,810,540	$18,328,697
4	VRTX	Vertex Pharmaceuticals Inc / Ma	30,705	$15,252,094
5	INCY	Incyte Corp This page	116,207	$13,173,225
6	REGN	Regeneron Pharmaceuticals, Inc.	20,126	$12,549,366
7	EXEL	Exelixis, Inc.	176,339	$9,594,604
8	CORT	Corcept Therapeutics Inc	102,823	$8,940,459

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,173,225	116,207	+24.6%	Shares	Sole	2026-08-19
2026-03-31	$8,778,195	93,266	+3.0%	Shares	Sole	2026-05-15
2025-12-31	$8,947,475	90,589	+10.5%	Shares	Sole	2026-02-18
2025-09-30	$6,950,518	81,954	+154.5%	Shares	Sole	2025-11-14
2025-06-30	$2,193,092	32,204	+64.8%	Shares	Sole	2025-08-14
2025-03-31	$1,183,328	19,543	+156.3%	Shares	Sole	2025-05-15
2024-12-31	$526,589	7,624	+131.4%	Shares	Sole	2025-02-14
2024-09-30	$217,799	3,295	-90.6%	Shares	Sole	2024-11-14
2021-06-30	$2,962,049	35,208	+0.0%	Shares	Sole	2021-08-10
2021-03-31	$2,860,297	35,195	+2.0%	Shares	Sole	2021-08-10
2020-12-31	$3,001,505	34,508	+1.1%	Shares	Sole	2021-02-12
2020-09-30	$3,062,018	34,121	-0.2%	Shares	Sole	2020-12-10
2020-06-30	$3,553,382	34,177	-0.3%	Shares	Sole	2020-08-10
2020-03-31	$2,509,372	34,267	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.